Highlights 26 • l and k light chain diversity is equivalent to heavy chain diversity 27 • High diversity is present despite limited gene segment usage 28 • PRRSV infection increases abundance of dominant l and k VJ clones 29 • High levels of variation are present among animals 30 31 Abstract 32 Antibody responses are fundamentally important to effector and memory mechanisms of disease 33 resistance. Antibody repertoire diversity and its response to natural infection is poorly understood, yet is a 34 prerequisite for molecular and structural elucidation of functionally protective immunity to viral 35 infections. Using a swine model of mammalian viral infection, we observed marked changes following 36 infection with the major porcine pathogen, porcine reproductive and respiratory syndrome virus 37 (PRRSV). Deep sequencing of >516,000 light chain VJ mRNA genes showed that, similar to humans, 38 swine utilize both lambda and kappa loci equivalently. However, V and J gene usage were highly 39 restricted; ≥99% of lambda light chains were IGLV3 and IGLV8 family members joined to IGLJ2 or 40 IGLJ3, and 100% of kappa locus transcripts were IGKV1 or IGKV2 with only IGKJ2. Complementarity-41 determining region (CDR) variation was limited. Nevertheless, total diversity richness estimates were 2.3 42 x 10 5 for lambda and 1.5 x 10 5 for kappa, due in part to extensive germline variation in framework regions 43 and allelic variation. Infection by PRRSV reduced total richness due to expression of several highly 44 abundant clonal populations. Antibody light chain repertoires differed substantially among individuals, 45 thus illustrating extensive potential variation in immune response in outbred populations. These findings 46 demonstrate that individual variation in light chain repertoires may be an important component of variable 47 antibody responses to infection and vaccination, and that swine are a relevant model of human antibody 48 diversification in which the immune response capacity is critical to understanding individual variation in 49 immune protection against disease. 50 51